Triple GLP-1/GIP/Glucagon Agonists: Where the Research Stands
How a single peptide came to activate three proglucagon-family receptors, what phase 2 trials of the class reported, and what is still unknown.
Topic
Metabolic & GLP
Incretin and multi-agonist research: GLP-1, GIP, glucagon and amylin pathways, and what the trial literature actually shows.
5 notes in this topic
What Are GLP-1 Peptides? Incretin Biology for Researchers
The biology behind GLP-1: where it comes from, what it does, why the native hormone lasts two minutes, and how synthetic analogues were built to last a week.
MOTS-c: A Mitochondrial-Derived Peptide in Metabolic Research
What the literature shows about MOTS-c, a 16-amino-acid peptide encoded in mitochondrial DNA: AMPK signaling, mouse exercise studies and one small human trial.
GLP-1 vs. GIP vs. Glucagon Receptors: Why Multi-Agonism Emerged
Three related receptors, three different jobs. How the biology of GLP-1, GIP and glucagon receptors led from selective agonists to dual and triple agonists.
Semaglutide vs. Tirzepatide: Single vs. Dual Agonism in the Literature
What the SUSTAIN, STEP, SURPASS and SURMOUNT programs show about a GLP-1 agonist and a GLP-1/GIP dual agonist, and what the comparison does and does not settle.
All content in the research library is educational and intended for qualified researchers. Products referenced are for laboratory research use only and are not approved for human or veterinary use. Nothing here is medical advice.